(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Latest News Releases From The Newsroom

Chijet Motor Debuts on Nasdaq, Market Experts Bullish on Ambrx, FibroGen, Bowlero, REGENXBIO and Kopin

June 02nd, 2023

Chijet Motor Company, Inc. (Nasdaq: CJET) achieved a significant milestone as it officially joined the ranks of NASDAQ-listed companies under the ticker symbol "CJET" on Friday.  With a core focus on the development, manufacturing, sales, and. Read more

FTC Finalizes Order Against Motocross and ATV Parts Maker Cycra for False Made in USA Claims

June 02nd, 2023

Washington D.C. / CRWE PRESS RELEASE / June 2, 2023  -  The Federal Trade Commission has finalized its order against motocross and ATV parts maker Cycra and its officer, Chad James, for falsely claiming that the company&rsquo. Read more

Yunji Soars on Narrower Loss; Ginkgo Bioworks, Xcel Energy Downgraded

June 02nd, 2023

Yunji Inc. (Nasdaq: YJ) experienced a significant surge in its stock price as the company reported a narrower loss in its financial results.  In the first quarter of 2023, Yunji recorded a net loss of RMB22.9 million (US$3.3 million), represe. Read more

LAVA Therapeutics: Janssen Picks Gamma-Delta T-Cell Engager Bispecific Antibody; Chemours, DuPont, and Corteva Reach Agreement in Principle

June 02nd, 2023

LAVA Therapeutics N.V. (Nasdaq: LVTX) has announced a major milestone under the research collaboration initiated in 2020 with Janssen Biotech, Inc., a subsidiary of the Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE: JNJ).  Janss. Read more

Tilly's, Guidewire Software, ChargePoint, Dell Technologies, and Zscaler: A Snapshot of Financial Reports

June 02nd, 2023

Tilly's, Inc. (NYSE: TLYS) released its first-quarter fiscal 2023 financial report, revealing a loss of $0.40 per share, slightly exceeding the consensus estimate of a $0.33 per share loss.  Looking ahead to the second quarter, the company ex. Read more

Bipartisan Budget Agreement: President Biden Hails Historic Achievement for America's Economy and Future

June 02nd, 2023

In a historic moment for the United States, President Joe Biden praised the bipartisan effort displayed by Senators in passing the Bipartisan Budget Agreement. The President emphasized the significance of this achievement, highlighting that it not on. Read more

Mixed Earnings Reactions: Broadcom, SentinelOne, PagerDuty, Five Below, Asana

June 02nd, 2023

Broadcom Inc. (Nasdaq: AVGO) reported adjusted earnings per share (EPS) of $10.32 for the second quarter of fiscal 2023, surpassing the consensus estimate of $10.08.  Looking ahead to the third quarter, Broadcom anticipates revenue of approxi. Read more

Lululemon (LULU), Elastic (ESTC), and Samsara (IOT) Beat Expectations: Market Reactions

June 01st, 2023

Lululemon Athletica Inc. (Nasdaq: LULU) reported a strong financial performance for the first quarter of fiscal 2023. The company's earnings per share (EPS) for the quarter stood at $2.28, exceeding the consensus estimate of $1.98.  Lululemon. Read more

Stratasys Offered New Acquisition Bid, MongoDB Beats Estimates, Zumiez Falls Short: Market Update

June 01st, 2023

Stratasys Ltd. (Nasdaq: SSYS) has received an unsolicited proposal from 3D Systems Corporation (NYSE: DDD) to acquire Stratasys for a combination of $7.50 in cash and 1.2507 newly issued shares of 3D Systems per ordinary share of Stratasys.  . Read more

Bullishness on Homebuilding Stocks: TMHC, TOL, TPH, MTH, PHM, DHI, KBH

June 01st, 2023

Taylor Morrison Home Corporation (NYSE: TMHC), a leading national homebuilder and developer, has been initiated with a Hold rating by Deutsche Bank, with a price target of $50.  With a closing price of $42.85 on Thursday, $TMHC presents a pot. Read more